Disease | c syndrome |
Phenotype | C0007113|rectal cancer |
Sentences | 9 |
PubMedID- 23546613 | Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. |
PubMedID- 21696633 | Initial findings suggest that a combination of components of the metabolic syndrome is associated with risk of colorectal cancer development (men: rr: 1.25 (95% ci; 1.18-1.32; women: rr 1.14 (95% ci; 1.02-1.18)[42], endometrial cancer (rr 1.37, 1.28-1.46)[43], bladder cancer in men (rr: 1.1, 1.01-1.18)[44] and pancreatic cancer in women (rr,1.58; 1.34-1.87)[45]. |
PubMedID- 25862880 | Association of liver steatosis with colorectal cancer and adenoma in patients with metabolic syndrome. |
PubMedID- 20395126 | Metabolic syndrome is associated with colorectal cancer in men. |
PubMedID- 21490705 | When the family history includes two or more relatives with colorectal cancer, the possibility of a genetic syndrome is increased substantially [3, 7]. |
PubMedID- 21317959 | Aim: 8-12% of colorectal cancers are associated with genetic syndromes. |
PubMedID- 26119923 | Purpose: to determine the relationship between the receipt of colony-stimulating factors (csfs) with erythropoiesis-stimulating agents (esas) and the risk of developing venous thromboembolism (vte), stroke, heart disease, and myelodysplastic syndrome (mds) in patients with colorectal cancer. |
PubMedID- 22044849 | Our results suggest that the positive association of the metabolic syndrome with risk of colorectal cancer is largely accounted for by serum glucose levels and systolic blood pressure. |
PubMedID- 26150580 | A prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer. |
Page: 1